NIH-funded research R01 grant

How low oxygen in pregnancy changes uterine blood flow

Official title: Mechanisms of uterine artery hemodynamics adaptation to pregnancy and gestational hypoxia

Funded at Loma Linda University · NIH-11323619 · Data updated 2026-11-12

Researchers are learning how low oxygen during pregnancy changes uterine blood flow and how that can affect pregnant people and their babies.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionLoma Linda University
NIH-funded
Lab location1 site (Loma Linda, UNITED STATES)
Project startJune 1, 2023
Project endApril 30, 2027
Funding year2026
Award (this year)$793,792
NIH project number5R01HL169157-04
Project IDNIH-11323619 on NIH RePORTER

Who could benefit from this research

Could help

This line of work is most relevant to pregnant people concerned about low‑oxygen exposures (for example at high altitude) or at risk for preeclampsia or fetal growth restriction.

Less likely to help

People who are not pregnant or whose pregnancy risks are unrelated to uterine blood flow or low oxygen exposure are unlikely to get direct benefit from this work.

What this research studies

If I'm pregnant, I want to know how low oxygen could harm blood flow to my baby; this work looks into that problem. The team uses pregnant sheep as a model and laboratory methods (including RNA‑seq and molecular studies) to study uterine artery function. They focus on a protein called Rad and L‑type CaV1.2 calcium channels that control artery contraction, and they compare signals in sheep and humans including hormone effects. The goal is to understand why adaptation to chronic low oxygen sometimes fails and to point toward ways to protect mothers and babies from preeclampsia and fetal growth restriction.

Why it matters

Potential benefit: If successful, this work could point to new tests or treatments to prevent or reduce pregnancy complications like preeclampsia and fetal growth restriction caused by low oxygen.

How similar studies have gone: Previous animal studies have shown that gestational hypoxia raises uterine vascular resistance and blood pressure, but targeting the Rad/CaV1.2 mechanism is a novel approach not yet tested in patients.

Where this research is happening

  • Loma Linda University
    Loma Linda, United States
    Active

Researchers

  • Principal investigator: Zhang, Lubo — Loma Linda University
  • Study coordinator: Zhang, Lubo

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.